PercAssist, Inc. is a privately held company that has developed “The first minimally invasive, ECG synchronized, extra-vascular for treating severe heart failure”. PercAssist provides an option that is procedurally simple, is easily tolerated, reduces recovery time, decreases long-term complications and hospitalizations, and increases survival and quality of life.
There is an ever-increasing demand in this large market space and PercAssist, with their Founding Team and Clinical Advisory Board Members are driven by the desire to tackle this massive unmet patient need.
CEO: Gerardo Noriega
Company Headquarters: Santa Clara, CA